Picture of International Biotechnology Trust logo

IBT — International Biotechnology Trust News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsBalancedSmall Cap

Intnl. Biotechnology - Appointment of Non-Executive Director

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240827:nRSa6511Ba&default-theme=true

RNS Number : 6511B  Intl. Biotechnology Trust PLC  27 August 2024

International Biotechnology Trust plc

(the "Company")

 

 

Appointment of Non-Executive Director

 

The Board of International Biotechnology Trust plc is pleased to announce the
appointment of Alexa Henderson as an independent Non-Executive Director of the
Company with effect from 1 January 2025.

 

Alexa will succeed Caroline Gulliver as Chair of the Company's Audit
Committee. In line with Alexa's date of appointment it is now intended that
Caroline Gulliver, who has served nine years on the Board, will stand for
re-election at the Company's 2024 Annual General Meeting, and remain on the
Board for a short period to ensure a smooth transition. On appointment, Alexa
will also join the Management Engagement Committee and Nomination Committee.

 

Alexa has over 30 years' experience in finance, accounting and audit having
worked at KPMG, Arthur Andersen and Deutsche Bank (WM Company). Alexa is
currently Chair of JPMorgan Japan Small Cap Growth and Income plc (anticipated
to retire in October 2024), and a non- executive director of abrdn UK Smaller
Companies Growth Trust plc and WAM Leaders Limited, an Australian listed
investment company. Previous directorships include Scottish Building society
(which she chaired for four years), CT Property Trust Limited, Bravura
Solutions Limited and Adam & Company Group PLC. Alexa holds a BSc in
Accounting and Economics from Edinburgh University and is a Chartered
Accountant.

 

The Company's Chair, Kate Cornish-Bowden, said "We are delighted to welcome
Alexa to the Board. She brings with her extensive global experience chairing
audit committees for a number of financial institutions including investment
trusts."

 

In accordance with paragraph 6.4.8 of the Listing Rules, it is confirmed that
there are no further details to be disclosed in relation to Alexa Henderson.

 

Enquiries:

 

Schroder Investment Management Limited

Kerry Higgins

Tel: 0207 658 6000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAZZGZRKFFGDZM

Recent news on International Biotechnology Trust

See all news